References
- Hill, B.T., Perrin, D. and Kruczynski, A (2000) Inhibition of RAS-targeted prenylation: protein famesyl transerase inhibitors revisited Crit. Rev. Oncol. Hematol. 33: 7-23 https://doi.org/10.1016/S1040-8428(99)00053-0
- Qian, Y., Sebti, S. M. and Hamilton, A D. (1997) Famesyltransferase as a target for anticancer drug design. John Wiley & Sons, Inc. Biopoly. 43: 25-41 https://doi.org/10.1002/(SICI)1097-0282(1997)43:1<25::AID-BIP4>3.0.CO;2-2
- Kohl, N. E., Wilson, F. R, Mosser, S. D., Giuliani, E. A., DeSolms, S. J., Conner, M. W., Anthony, N. J., Holtz, W. J., Gomez, R P.,Lee, T.J., Smith, R. L., Hartman, G. D., Gibbs, J. B. and Oliff, A. (1994) Protein Famesy1transferase Inhibitors Block the Growth of ras-Dependent Tumors in Nude Mice. Proc. Natl. Acad. Sci. U.S.A. 91: 9141-9145 https://doi.org/10.1073/pnas.91.19.9141
- Sun, J., Qian, Y, Hamilton, A. D. and Sebti, S. M. (1995) Ras caaX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with k-ras mutation and p53 deletion. Caancer Res. 55: 4243-4247
- Kohl, N. E., Mosser, S. D., DeSolms, S. J., Giuliani, E. A, Pompliano, D. L., Graham, S. L., Smith, R. L., Scolnick, E. M., Oliff, A and Gibbs, J. B. (1993) Selective inhibition of ras-dependent transformation by a famesyltransferase inhibitor. Science 260: 1934-1937 https://doi.org/10.1126/science.8316833
- Jayasuriya, H., Silverman, K. C., Zink, D. L., Jenkins, R. G., Sanchez, M., Pelaez, F., Vilella, D., Lingham, R. B. and Singh, S. B. (1998) Clavaric acid: A triterpenoid inhibitor of famesyl protein transferase from Clavariadelphus truncates. J. Nat. Prod. 61: 1568-1570 https://doi.org/10.1021/np980200c
- Singh, S.B., Zink, D.L., Liesch, J.M., Goetz, M.A., Jenkins, R.G., Nallin-Omstead M., Silverman, K.C., Bills, G.F., Mosley, RT., Gibbs, J.B., Albers-Schonberg G., Lingham, R.B.(1993) Isolation and structure of chaetomellic acid A and B from Chaetomella acustiseta: famesyl pyrophosphate mimics inhibitors of Ras famesyl-protein transderase.Tetrahedron. 49: 5917-5926 https://doi.org/10.1016/S0040-4020(01)87178-7
- Lee, S. H., Kim, M. J., Bok, S. H., Lee, H., Kwon, B. M., Shin, J. and Seo, Y. (1998) Arteminolide, an inhibitor of famesyl transferase from Artemisia sylvatica. J. Org. Chem. 63: 7111-7113 https://doi.org/10.1021/jo980919p
- Kwon, B. M., Lee, S. H., Kim, K S., Lee, I. R, Hong, U. C. and Bok, S. H. (1997) Bioorganic & Med. Chem. Lett. 7: 971-974 https://doi.org/10.1016/S0960-894X(97)00139-X
- Kwon, B. M., Cho, Y K, Lee, S. H., Nam, J. Y, Bok, S. H., Chun S. K, Kim, J. A and Lee, I. R (1996) 2-Hydroxycinnamaldehyde from stem bark of Cinnamomum cassia. Planta Med. 62: 183-184 https://doi.org/10.1055/s-2006-957851
- Tamanoi, F, Gau, C. L., Jiang, C, Edamatsu, H. and KatoStankiewicz, J. (2001) Protein famesylaion in mammalian cells: effects of famesyltransferase inhibitors on cancer cells. Cell. Mol. Life. Sci. 58: 1636-1649 https://doi.org/10.1007/PL00000802
- Johnston, S., Ellis, P. Houston, S. et al.: (2000) A phase II study of the famesyltransferase inhibitor Rl15777 in patients with advanced breast cancer[abstract]. Proe. Am. Soc. Oncol.19: 83a
-
Reiss, Y., Goldstein, J. L., Seabra, M. C, Casey, P. J. and Brown, M. S. (1990) Inhibition of purified
$p21^{ras}$ famesyl: protein transferase by Cys-AAX tetrapeptides. Cell. 62: 8188